Oakrum Pharma and ANI Pharmaceuticals Announce the Launch of Betaine Anhydrous Powder, the first Generic Version of Cystadane® (betaine anhydrous for oral solution) Powder, Including 180 Days of Exclusivity PR Newswire (US) - 5:00:00 PMĪnnual Statement of Changes in Beneficial Ownership (5) Edgar (US Regulatory) - 4:44:12 PMĬurrent Report Filing (8-k) Edgar (US Regulatory) - 4:18:42 PMĪNI Pharmaceuticals Announces Commercial Availability of Purified Cortrophin™ Gel (Repository Corticotropin Injection USP) for Multiple Chronic Autoimmune Disorders Business Wire - 6:50:00 AM Current Report Filing (8-k) Edgar (US Regulatory) - 4:57:35 PMĪNI Pharmaceuticals Strengthens Rare Disease Business Unit Leadership Team Business Wire - 6:50:00 AMĬurrent Report Filing (8-k) Edgar (US Regulatory) - 4:11:37 PM
0 kommentar(er)
